Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Other |
Changes in Barriers to the practice of Physical Activities of Daily Living |
The possible answers to the questionnaire Barriers to the practice of Physical Activities of Daily Living are never, rarely, sometimes, almost always or always and the score for each item varies from 0 to 4. It will be considered as limiting domain for physical activities those in which individuals report a value equal to or greater than 3 in at least half of the barriers. |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Other |
Change in asthma exacerbation |
Asthma exacerbation will be assessed by the following criteria: the use of =4 puffs of rescue medication per 24 hours during a 48-hour period, a need for systemic corticosteroids, an unscheduled medical appointment, and either a visit to an emergency room or hospitalization |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Other |
Change in Behavioral Stage for physical activity practice |
The Behavioral Stage Assessment Questionnaire for the Practice of Physical Activity qualitatively assesses thinking in relation to the practice of physical activity, and may present the following stages of behavior: 1. Pre-contemplation; 2. Contemplation; 3. Preparation; 4. Action; 5- Maintenance. |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Other |
Pulmonary function |
Lung volumes will be assessed by spirometry |
Baseline |
|
Other |
Change in anthropometric indexes |
Waist circumference (cm) and hip circumference (cm) will be combined to report wait to hip ratio (WHR) |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Primary |
Change in physical activity levels |
Physical activity will be objectively quantified using a movement sensor (ActiGraph, Pensacola, USA) for 7 consecutive days on the hip using an elastic belt. |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in sedentary behaviour |
Sedentary behaviour will be objectively quantified using a movement sensor (ActiGraph, Pensacola, USA) for 7 consecutive days on the hip using an elastic belt. Sedentary behaviour will be quantify by the time spent sedentary (< 100 counts/min). |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in asthma clinical control |
Clinical control will be evaluated by the Asthma Control Questionnaire (ACQ). The ACQ contains 7 items rated on a 7-point scale (0 = without limitation, 6 = maximum limitation), with a higher score indicating worse control. Scores lower than 0.75 are associated with good asthma control, whereas scores greater than 1.5 are indicative of poorly controlled asthma, and a change of at least 0.5 points in the ACQ score is regarded as clinically significant. |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in Health Factors Related to Quality of Life in Asthma |
Health related quality of life will be assessed by Asthma Quality Life Questionnaire (AQLQ). The AQLQ consists of 32 items rated on a 7-point scale (1 = great deal, 7 = not at all) divided into the following 4 domains: activity limitations, symptoms, emotional function and environmental stimuli. Higher AQLQ scores indicate a better quality of life, and treatments resulting in a 0.5-point increase in scores following an intervention are considered to be clinically effective. |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in psychosocial symptoms |
Symptoms of anxiety and depression symptoms will be assessed by the Hospital Anxiety and Depression scale (HADs), which consists of 14 items divided into 2 subscales (7 for anxiety and 7 for depression). Each item is scored from 0 to 3, with a maximum score of 21 points for each subscale. A score greater than 8/9 in each subscale suggests a diagnosis of either anxiety and/or depression. |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in body composition - Weight |
Bioimpedance (Octopolar InBody 720). |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in body composition - Fat mass |
Bioimpedance (Octopolar InBody 720). |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in body composition - Visceral adiposity area |
Bioimpedance (Octopolar InBody 720). , Fat-free mass, and skeletal muscle mass will be calculated. |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in body composition - Fat-free mass |
Bioimpedance (Octopolar InBody 720). |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|
Secondary |
Change in body composition - Skeletal muscle mass |
Bioimpedance (Octopolar InBody 720). |
Change from baseline at 8 weeks of intervention and at 16 weeks post intervention |
|